Rulings
SEBI: Allows Rakesh Jhunjhunwala’s settlement application in Aptech insider trading case
SEBI: Mere selling of shares in illiquid scrip doesn’t amount to trade manipulation
SEBI: Investment Advisers cannot charge brokerage fees, earn commission by referring clients
SEBI: Exonerates Independent Director in synchronised trades case, gives him “benefit of doubt”
SAT: Quashes SEBI order debarring Non-executive Director, absent role in fraudulent GDR issue
SEBI: No distinction between voluntary/involuntary shareholding-changes under PIT Regulations; Penalizes Promoters for default
SEBI: Restrains Sterling Biotech's Directors, MD from market, for devising fraudulent GDRs scheme
SAT: Stays SEBI order debarring Franklin Templeton’s former Head from market
HC: Dismisses petition challenging SEBI Circular prescribing modes of charging fee by Investment Advisors
SEBI: Penalises company, its MD, Executive Director for mis-utilizing IPO funds, defrauding investors